It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Liquid chromatography (LC) coupled with data-independent acquisition (DIA) mass spectrometry (MS) has been increasingly used in quantitative proteomics studies. Here, we present a fast and sensitive approach for direct peptide identification from DIA data, MSFragger-DIA, which leverages the unmatched speed of the fragment ion indexing-based search engine MSFragger. Different from most existing methods, MSFragger-DIA conducts a database search of the DIA tandem mass (MS/MS) spectra prior to spectral feature detection and peak tracing across the LC dimension. To streamline the analysis of DIA data and enable easy reproducibility, we integrate MSFragger-DIA into the FragPipe computational platform for seamless support of peptide identification and spectral library building from DIA, data-dependent acquisition (DDA), or both data types combined. We compare MSFragger-DIA with other DIA tools, such as DIA-Umpire based workflow in FragPipe, Spectronaut, DIA-NN library-free, and MaxDIA. We demonstrate the fast, sensitive, and accurate performance of MSFragger-DIA across a variety of sample types and data acquisition schemes, including single-cell proteomics, phosphoproteomics, and large-scale tumor proteome profiling studies.
DIA-MS has emerged as a widely used technological platform for quantitative protein profiling. Here, the authors develop MSFragger-DIA, a robust and fast tool to directly identify peptides from DIA spectra. It demonstrates excellent performance across applications from large-scale tumor studies to single-cell proteomics.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Teo, Guo Ci 1
; Kong, Andy T. 2 ; Fröhlich, Klemens 3
; Li, Ginny Xiaohe 1 ; Demichev, Vadim 4 ; Nesvizhskii, Alexey I. 2
1 University of Michigan, Department of Pathology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000 0004 1936 7347)
2 University of Michigan, Department of Pathology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000 0004 1936 7347); University of Michigan, Department of Computational Medicine and Bioinformatics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000 0004 1936 7347)
3 University of Basel, Proteomics Core Facility, Biozentrum, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642)
4 Charité – Universitätsmedizin Berlin, Department of Biochemistry, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662); University of Cambridge, Department of Biochemistry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)




